Celestine M. Trinidad - Search Results

Year	Number of Results
2018	3
2019	2
2022	1
2023	1

1

Rare Variants of Dermatofibrosarcoma Protuberans: Clinical, Histologic, and Molecular Features and Diagnostic Pitfalls.

Trinidad CM, Wangsiricharoen S, Prieto VG, Aung PP. Trinidad CM, et al. Dermatopathology (Basel). 2023 Jan 29;10(1):54-62. doi: 10.3390/dermatopathology10010008. Dermatopathology (Basel). 2023. PMID: 36810566 Free PMC article. Review.

2

Update on eighth edition American Joint Committee on Cancer classification for cutaneous melanoma and overview of potential pitfalls in histological examination of staging parameters.

Trinidad CM, Torres-Cabala CA, Curry JL, Prieto VG, Aung PP. Trinidad CM, et al. J Clin Pathol. 2019 Apr;72(4):265-270. doi: 10.1136/jclinpath-2018-205417. Epub 2018 Oct 1. J Clin Pathol. 2019. PMID: 30275100 Review.

3

Update on eighth edition American Joint Committee on Cancer classification for Merkel cell carcinoma and histopathological parameters that determine prognosis.

Trinidad CM, Torres-Cabala CA, Prieto VG, Aung PP. Trinidad CM, et al. J Clin Pathol. 2019 May;72(5):337-340. doi: 10.1136/jclinpath-2018-205504. Epub 2019 Jan 13. J Clin Pathol. 2019. PMID: 30636696 Review.

4

Phase 1/2 trial evaluating the effectiveness and safety of dose-adapted Hypofractionated pelvic radiotherapy for Advanced Cervical cancers INeligible for ChemoTherapy (HYACINCT).

Bacorro W, Baldivia K, Dumago M, Bojador M, Milo A, Trinidad CM, Mariano J, Gonzalez G, Sy Ortin T. Bacorro W, et al. Acta Oncol. 2022 Jun;61(6):688-697. doi: 10.1080/0284186X.2022.2048070. Epub 2022 Mar 14. Acta Oncol. 2022. PMID: 35285405 Clinical Trial.

5

The isomiR-140-3p-regulated mevalonic acid pathway as a potential target for prevention of triple negative breast cancer.

Bhardwaj A, Singh H, Trinidad CM, Albarracin CT, Hunt KK, Bedrosian I. Bhardwaj A, et al. Breast Cancer Res. 2018 Dec 11;20(1):150. doi: 10.1186/s13058-018-1074-z. Breast Cancer Res. 2018. PMID: 30537987 Free PMC article.

6

Dermatologic toxicity from novel therapy using antimicrobial peptide LL-37 in melanoma: A detailed examination of the clinicopathologic features.

Dolkar T, Trinidad CM, Nelson KC, Amaria RN, Nagarajan P, Torres-Cabala CA, Ivan D, Prieto VG, Tetzlaff MT, Curry JL, Aung PP. Dolkar T, et al. Among authors: trinidad cm. J Cutan Pathol. 2018 Jul;45(7):539-544. doi: 10.1111/cup.13262. Epub 2018 May 16. J Cutan Pathol. 2018. PMID: 29665030

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

6 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year